Good news! Australian medicine once again benefits the world, according to the Sydney Morning Herald, a study published in the New England Journal of Medicine (the New England Journal of Medicine) confirmed that The Australian melanoma Institute (Melanoma Institute Australia) has successfully combined new therapies. Doctors will soon acquire new weapons as they fight melanoma, the deadliest skin cancer. The findings were presented Monday at the 2017 Congress of the European Society of Oncology in Spain.
Multiple tests to find out the truth.
Professor Georgina Lang (right) and the interviewee Ray inside Sydney-based Australian melanoma Research Institute, Sydney Herald Morning Post
About 14000 people are expected to be diagnosed with melanoma in Australia this year, and about 1800 people are expected to die as a result, according to sources. The new treatment could effectively stop the spread of melanoma and save more lives. "our ultimate goal is to turn melanoma into a chronic disease, not a major terminal disease," said Professor Georgina (Professor Georgina Long), director of joint medicine at the institute. The good news is that we are now closer to achieving this goal. "
It is understood that the researchers have conducted two previous trials, one is immunotherapy and the other is targeted therapy, both of which have successfully prevented the spread of stage III melanoma patients. The tumors of these patients have been surgically removed. The so-called immunotherapy, by taking specific drugs for a year to help the immune system restart, which in turn can attack melanoma cells. "patients receive another 12 months of medication after surgery, which reduces the recurrence rate of cancer from 50% to 25% (Epimab, Ipilimumab) and 35%) (Navumab, Nivolumab). This is a considerable achievement. "
Targeted therapy is to prevent melanoma from spreading by blocking specific genes. "during the 12-month period of taking this drug-compared to doing nothing, our standard is to remove melanoma," he said. Then look-the chance of melanoma recurrence was reduced by 53%. " "this means that assuming a 50 percent chance of melanoma recurrence and death, we can reduce it to 25 percent or less," Professor Lang explained.
No longer "talking about tumor Color change"
Professor MacArthur, Executive Director of the Victoria Comprehensive Cancer Centre, Sydney Morning Herald
Under normal circumstances, stage III patients had a 40-70% risk of relapsing cancer and developing fatal melanoma.
Professor MacArthur (Professor Grant McArthur), Executive Director of the Victorian Comprehensive Cancer Center, said the study was "extremely important." Because melanoma is one of the most difficult cancers to treat, chemotherapy has little effect. Now, "We can get ahead and try to kill melanoma before it recur and spread all over the body."
Rene (Renae Aslanis), a history teacher from the new town of (Newtown) in Sydney, was one of 870 patients undergoing targeted therapy. The third-stage patient`s survival rate was 54 percent at the time of her surgery, but four and a half years later, despite side effects such as headaches and weight gain, she felt she could "imagine the future" now.
Source of Pictures ~ Australian Melanoma Research Foundation
Data show that in recent decades, the incidence of melanoma in Australia has almost doubled, the "sun-scorched country" is the world`s second highest incidence of melanoma, after New Zealand. Editor reminds you, Australia`s solar ultraviolet radiation is higher, and people generally like outdoor and sunlight, so go out and play remember to pay attention to sunscreen! Watch the sun! Watch the sun!
